Nordwand Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-250
| Closed | -$6.34K | – | 203 |
|
|
2025
Q1 | $6.34K | Hold |
250
| – | – | ﹤0.01% | 87 |
|
|
2024
Q4 | $6.63K | Hold |
250
| – | – | ﹤0.01% | 96 |
|
|
2024
Q3 | $7.24K | Hold |
250
| – | – | ﹤0.01% | 95 |
|
|
2024
Q2 | $7K | Sell |
250
-200
| -44% | -$5.6K | ﹤0.01% | 116 |
|
|
2024
Q1 | $12.5K | Buy |
450
+250
| +125% | +$6.94K | ﹤0.01% | 119 |
|
|
2023
Q4 | $5.76K | Hold |
200
| – | – | ﹤0.01% | 132 |
|
|
2023
Q3 | $6.63K | Buy |
+200
| New | +$6.63K | ﹤0.01% | 104 |
|
|
2023
Q2 | – | Sell |
-44,709
| Closed | -$1.82M | – | 128 |
|
|
2023
Q1 | $1.82M | Sell |
44,709
-55,195
| -55% | -$2.25M | 0.3% | 24 |
|
|
2022
Q4 | $5.12M | Buy |
+99,904
| New | +$5.12M | 0.64% | 21 |
|